The hallmarks of aging framework (Lopez-Otin et al., updated 2023) identifies twelve interconnected drivers of biological aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation (inflammaging), and dysbiosis. Peptide research in longevity biology intersects multiple of these hallmarks simultaneously, distinguishing it from single-target pharmacology. This article reviews the 2026 state of preclinical evidence for longevity-relevant peptides, with specific attention to mechanism specificity and hallmark coverage.
Epitalon: TERT Activation and Telomere Dynamics
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed at the St. Petersburg Institute of Bioregulation based on pineal gland peptide extracts. Its most studied mechanism involves TERT (telomerase reverse transcriptase) activation: Epitalon treatment in cultured human fetal fibroblasts (passage 20–30) has been shown to extend replicative lifespan by 3–5 passages versus control, correlating with detectable TERT mRNA increase (approximately 2-fold by qRT-PCR) and reduced mean single-telomere-length attrition rate as measured by Q-FISH. The proposed mechanism involves epigenetic activation of the TERT gene promoter through histone modification changes—Epitalon treatment in aging rats shows decreased H3K9me3 (heterochromatin mark) and increased H3K4me3 (active transcription mark) at the TERT locus by ChIP assay. Epitalon also modulates the neuroendocrine axis: melatonin synthesis enzyme upregulation (hydroxyindole-O-methyltransferase, HIOMT) in pineal gland models suggests a chronobiological dimension linked to circadian rhythm restoration—itself a mechanism connecting to multiple aging hallmarks including DNA repair cycle timing, mitophagy, and NAD+ oscillation.
SS-31 and Mitochondrial Hallmark Coverage
SS-31 (Elamipretide) addresses mitochondrial dysfunction through IMM cardiolipin binding (reviewed in detail in Post 60). In longevity biology context, its significance extends beyond energy production: cardiolipin oxidation is a mitophagy trigger (recognized by PINK1/Parkin pathway), and SS-31's cardiolipin stabilization may reduce inappropriate mitophagy signaling in otherwise healthy mitochondria. In aged muscle satellite cells (24-month mice), SS-31 treatment preserved mitochondrial mass (assessed by COX4 and TOMM20 immunostaining) and reduced NLRP3 inflammasome activation—the principal mechanism linking mitochondrial damage to SASP-like inflammatory signaling in aged muscle. This cross-hallmark action (mitochondrial dysfunction + inflammaging + cellular senescence via paracrine SASP) makes SS-31 mechanistically relevant across multiple aging axes.
NAD+/SIRT6 Axis: Telomeric Heterochromatin and Genome Stability
SIRT6, a NAD+-dependent deacylase, has direct relevance to telomere maintenance. SIRT6 deacetylates H3K9Ac and H3K56Ac at telomeric chromatin, maintaining the repressive heterochromatin structure that prevents telomere fragility. SIRT6 also deacetylates H3K56Ac in the context of DNA DSB (double-strand break) repair, recruiting factors to subtelomeric damage sites. NAD+ depletion in aged tissues reduces SIRT6 activity, leading to: increased telomere fragility (elevated telomere signal-free ends by Q-FISH in SIRT6-conditional knockout cells), derepression of LINE-1 retrotransposons (a source of genomic instability), and elevated NF-κB transcriptional activity (an inflammaging driver). Direct NAD+ administration or NMN supplementation in aged fibroblasts restores SIRT6 activity and reduces the telomeric fragility index—providing a mechanistic link between NAD+ biology and the telomere attrition hallmark independent of TERT activation.
Integrative Research Framework: Multi-Hallmark Peptide Assessment
- Epitalon research parameters: 5–20 mg/kg/day SC in rodents; key readouts: TERT mRNA (qRT-PCR), telomere length (Q-FISH), HIOMT expression, serum melatonin, H3K9me3/H3K4me3 ChIP at TERT locus
- SS-31 longevity parameters: 3–10 mg/kg/day SC; key readouts: cardiolipin oxidation (NAO assay), NLRP3 expression, PINK1/Parkin levels, satellite cell self-renewal capacity
- NAD+ longevity parameters: tissue NAD+ (HPLC), SIRT6-H3K56Ac deacetylation (ChIP), LINE-1 methylation (bisulfite sequencing), telomere fragility index (Q-FISH)
- Purity standard for all: HPLC >99%, lot-traceable CoA
All compounds described are for laboratory and research use only. They are not approved for therapeutic, diagnostic, or clinical use in humans. Investigators should adhere to institutional and regulatory requirements for preclinical aging research.